Adenocarcinoma of the esophagus and gastroesophageal junction. Prognostic factors and results of therapy
β Scribed by Robert Fein; David P. Kelsen; Nancy Geller; Manjit Bains; Patricia McCormack; Murray F. Brennan
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 602 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND: The use of platinumβbased chemoradiation for esophageal cancer is routine, but it is unclear which class of cytotoxic are optimum. It was hypothesized that chemoradiotherapy with fluoropyrimidine, taxane, and camptothecin would have preserved or improved efficacy with no
## BACKGROUND. To assess the toxicity, local response, and survival associated with multimodality therapy in a cooperative group setting, patients with biopsy-proven clinical Stage I or II adenocarcinoma of the esophagus (staged according to 1983 American Joint Committee on Cancer criteria) or gast
This report is a retrospective analysis of 83 adults (>16 years of age) with histologically proven or presumed primary neoplasms of the thalamus, hypothalamus, midbrain, pons, and medulla. Patients were treated with combined surgery and postoperative irradiation or with irradiation alone a t the Was